AGL 38.54 Increased By ▲ 0.97 (2.58%)
AIRLINK 129.50 Decreased By ▼ -3.00 (-2.26%)
BOP 5.61 Decreased By ▼ -0.03 (-0.53%)
CNERGY 3.86 Increased By ▲ 0.09 (2.39%)
DCL 8.73 Decreased By ▼ -0.14 (-1.58%)
DFML 41.76 Increased By ▲ 0.76 (1.85%)
DGKC 88.30 Decreased By ▼ -1.86 (-2.06%)
FCCL 35.00 Decreased By ▼ -0.08 (-0.23%)
FFBL 67.35 Increased By ▲ 0.85 (1.28%)
FFL 10.61 Increased By ▲ 0.46 (4.53%)
HUBC 108.76 Increased By ▲ 2.36 (2.22%)
HUMNL 14.66 Increased By ▲ 1.26 (9.4%)
KEL 4.75 Decreased By ▼ -0.11 (-2.26%)
KOSM 6.95 Increased By ▲ 0.10 (1.46%)
MLCF 41.65 Decreased By ▼ -0.15 (-0.36%)
NBP 59.60 Increased By ▲ 1.02 (1.74%)
OGDC 183.00 Increased By ▲ 1.75 (0.97%)
PAEL 26.25 Increased By ▲ 0.55 (2.14%)
PIBTL 5.97 Increased By ▲ 0.14 (2.4%)
PPL 146.70 Decreased By ▼ -1.70 (-1.15%)
PRL 23.61 Increased By ▲ 0.39 (1.68%)
PTC 16.56 Increased By ▲ 1.32 (8.66%)
SEARL 68.30 Decreased By ▼ -0.49 (-0.71%)
TELE 7.23 Decreased By ▼ -0.01 (-0.14%)
TOMCL 35.95 Decreased By ▼ -0.05 (-0.14%)
TPLP 7.85 Increased By ▲ 0.45 (6.08%)
TREET 14.20 Decreased By ▼ -0.04 (-0.28%)
TRG 50.45 Decreased By ▼ -0.40 (-0.79%)
UNITY 26.75 Increased By ▲ 0.35 (1.33%)
WTL 1.21 No Change ▼ 0.00 (0%)
BR100 9,806 Increased By 37.8 (0.39%)
BR30 29,678 Increased By 278.1 (0.95%)
KSE100 92,304 Increased By 366.3 (0.4%)
KSE30 28,840 Increased By 96.6 (0.34%)

"Multiple Sclerosis (MS) is one of the most common neurological disorders and causes of disability in young adults," according to a 2008 WHO publication. Although some people with MS lead functional lives without acute disability, 60 percent of people with MS become incapable of walking only 20 years after the first onset of the disease, severely diminishing their quality of life.
Women are two to three times more likely to develop the disease than men, according to the National Multiple Sclerosis Society, US. Though the cause of this often-devastating illness is still largely unknown, new treatments are now available to manage the disease. To shed more lights on the issues related to MS, Aga Khan University Hospital (AKUH) hosted a public awareness programme highlighting treatments, symptoms and effects of MS in Pakistan.
MS is thought to be an autoimmune disease where the bodys defence system attacks the fatty tissue surrounding the nerves, brain and spinal cord. It has different symptoms ranging from numbness in the limbs to paralysis and double vision, all of which are caused when damage to this fatty tissue interferes with signals transmitted around the body through the nervous system.
Dr Mughis Sheerani, Consultant Neurologist, AKUH, said: "It is important that physicians in Pakistan recognise the early symptoms of MS so it is properly diagnosed and its progression controlled." He also added that an MRI scan of the brain with contrast was the gold standard test to confirm MS.
Patients who have MS usually suffer from multiple attacks that cause more damage as the disease progresses. "While no cure exists for the disease, there are new cutting edge treatments available to combat the progression of the disease," said Dr Mohammad Wasay, Consultant Neurologist, AKUH.
A database of MS patients has been set up at AKU, where two studies related to the genetic factors and progression of MS among Pakistani patients are underway. Research shows that new treatments modify how the disease progresses and helps tackle relapses and manage symptoms, allowing patients to live more comfortably with the disease.
To better equip patients to cope with the physical effect of the disease, Asim Mehmood, Physiotherapist, AKUH, spoke about various rehabilitation options open to patients and their families, including physical, occupational and speech therapy, among others.-PR

Copyright Business Recorder, 2009

Comments

Comments are closed.